BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//IBSAL - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IBSAL
X-ORIGINAL-URL:https://ibsal.es/en/
X-WR-CALDESC:Events for IBSAL
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250522
DTEND;VALUE=DATE:20250917
DTSTAMP:20250526T051508Z
CREATED:20250526T051508Z
LAST-MODIFIED:20250526T051508Z
UID:25066-1747872000-1758067199@ibsal.es
SUMMARY:Horizon Europe. Cluster 1: Health
DESCRIPTION:Features\nThe work program for Cluster 1 (Health) under Horizon Europe has been published:  Work Program Horizon Europe Cluster 1 Health 2025. It is part of the new Horizon Europe strategic plan for the 2025–2027 period. The main priorities focus on social cohesion\, inclusion\, and the overall health and well-being of Europeans\, in line with the European Pillar of Social Rights. Other key priorities include the need to modernize health care systems and to support an innovative\, sustainable\, and competitive health industry in Europe.   \nMore specifically\, Cluster 1 strives to contribute to six expected impacts as set forth in the Strategic Plan\, which are distributed across the following topics: \n\n  \nHORIZON-HLTH-2025-03-STAYHLTH-01-two-stage: Improving the quality of life of people with intellectual disabilities and their families \nHORIZON-HLTH-2025-03-ENVHLTH-01-two-stage: The Impact of Pollution on the Development and Progression of Brain Diseases and Disorders \nHORIZON-HLTH-2025-03-ENVHLTH-02-two-stage: Advancing knowledge on the impacts of micro- and nanoplastics on human health \nHORIZON-HLTH-2025-01-DISEASE-01: Testing the safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections \nHORIZON-HLTH-2025-03-DISEASE-02-two-stage: Advancing Innovative Interventions for Mental\, Behavioral\, and Neurodevelopmental Disorders \nHORIZON-HLTH-2025-01-DISEASE-03: Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential \nHORIZON-HLTH-2025-01-DISEASE-04: Leveraging Artificial Intelligence for Pandemic Preparedness and Response \nHORIZON-HLTH-2025-01-DISEASE-05: Support for the operations of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) \nHORIZON-HLTH-2025-01-DISEASE-06: Implementation research addressing strategies to strengthen health systems for equitable\, high-quality care and health outcomes in the context of noncommunicable diseases (GACD) \nHORIZON-HLTH-2025-01-DISEASE-07: Addressing the high burden on patients and under-researched medical conditions \nHORIZON-HLTH-2025-02-DISEASE-01: European Partnership for Brain Health \nHORIZON-HLTH-2025-02-DISEASE-02: European partnership to foster a European Research Area (ERA) for health research (Phase 2) \nHORIZON-HLTH-2025-01-CARE-01: End-user-driven application of generative artificial intelligence models in healthcare (GenAI4EU) \nHORIZON-HLTH-2025-01-TOOL-01: Enhancing Cell Therapies with Genomic Techniques \nHORIZON-HLTH-2025-01-TOOL-02: Advancing Cell Secretome-Based Therapies \nHORIZON-HLTH-2025-01-TOOL-03: Leveraging Multimodal Data to Advance the Applicability of Generative Artificial Intelligence in Biomedical Research (GenAI4EU) \nHORIZON-HLTH-2025-01-TOOL-05: Accelerating the translation of biotech research into innovative health therapies \nHORIZON-HLTH-2025-01-IND-01: Optimizing the Manufacturing of Advanced Therapy Medicinal Products (ATMPs) \nHORIZON-HLTH-2025-01-IND-02: Digitalization of Conformity Assessment Procedures for Medical Devices and In Vitro Diagnostic Medical Devices \nHORIZON-HLTH-2025-03-IND-03-two-stage: Facilitating the conduct of multinational clinical studies of orphan devices and/or highly innovative (“breakthrough”) devices \n\n**If you’re interested in any of our opportunities or need more information\, please don’t hesitate to contact us\, and we’ll send you the relevant information sheet.** \n\n\n\nRequirements:\nThese calls for proposals are aimed at multidisciplinary European consortia. Unless otherwise specified in the specific conditions of the call\, only legal entities that form a consortium will be eligible to participate in the actions\, provided that the consortium includes\, as beneficiaries\, three legal entities that are independent of one another\, each established in a different country\, in accordance with the following criteria:  \n\n\nat least one independent legal entity established in a Member State; and \n\n\nat least two other independent legal entities\, each established in different Member States or Associated Countries. \n\n\nLegal entities established in Russia\, Belarus\, or in territories of Ukraine not controlled by the government are not eligible. \nHow to apply\nApplications consist of two sections: \n-Part A (to be completed online) contains administrative information related to the consortium\, the budget\, and specific details of the call for proposals. \n-Part B (a template downloaded from the Commission’s website must be completed) contains the scientific and technical aspects of the project. \n  \nSubmission deadline.\nIf the application process consists of two phases\, these are the dates: \n-Single stage: September 16\, 2025 \n-Two stages: April 16\, 2026 \nIf the calls for applications are for a single phase\, the deadline is: \n-Single stage: September 16\, 2025
URL:https://ibsal.es/en/evento/horizon-europe-cluster-1-health/
CATEGORIES:Calls for research
END:VEVENT
END:VCALENDAR